Blueprint Medicines (BPMC) PT Raised to $139 at Wedbush, Following Strategic Business Update

Go back to Blueprint Medicines (BPMC) PT Raised to $139 at Wedbush, Following Strategic Business Update
(NASDAQ: BPMC) Delayed: 56.29 +0.93 (1.68%)
Previous Close $55.36    52 Week High $35.96 
Open $55.57    52 Week Low $13.04 
Day High $56.72    P/E N/A 
Day Low $54.59    EPS $0.00 
Volume 478,295